Stockholm - Delayed Quote SEK

Stayble Therapeutics AB (publ) (STABL.ST)

Compare
0.4260 +0.0280 (+7.04%)
At close: 12:41:10 PM GMT+1
Currency in SEK All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
16,094.6500
24,001.6500
24,952.4720
12,140.1140
14,984.4590
Operating Income
-16,094.6500
-24,001.6500
-24,952.4720
-12,140.1140
-14,984.4590
Net Non Operating Interest Income Expense
547.2620
410.2620
5.6720
-28.0710
-396.1680
Pretax Income
-15,691.9930
-23,736.9930
-24,525.9230
-12,090.3390
-15,487.4720
Net Income Common Stockholders
-15,691.9930
-23,736.9930
-24,525.9230
-12,090.3390
-15,487.4720
Diluted NI Available to Com Stockholders
-15,691.9930
-23,736.9930
-24,525.9230
-12,090.3390
-15,487.4720
Basic EPS
-0.28
-0.75
-1.72
-0.85
-1.74
Diluted EPS
-0.28
-0.75
-1.72
-0.85
-1.74
Basic Average Shares
43,720.9030
31,720.9030
14,228.3810
14,228.3810
8,925.8760
Diluted Average Shares
43,720.9030
31,720.9030
14,228.3810
14,228.3810
8,925.8760
Total Operating Income as Reported
-16,046.2680
-23,954.2680
-24,796.4290
-12,139.8610
-14,925.1290
Total Expenses
16,094.6500
24,001.6500
24,952.4720
12,140.1140
14,984.4590
Net Income from Continuing & Discontinued Operation
-15,691.9930
-23,736.9930
-24,525.9230
-12,090.3390
-15,487.4720
Normalized Income
-15,691.9930
-23,736.9930
-24,525.9230
-12,090.3390
-15,487.4720
Interest Income
596.0170
455.0170
33.6140
29.0190
--
Interest Expense
48.7550
44.7550
27.9420
57.0900
396.1680
Net Interest Income
547.2620
410.2620
5.6720
-28.0710
-396.1680
EBIT
-15,643.2380
-23,692.2380
-24,497.9810
-12,033.2490
-15,091.3040
EBITDA
-15,643.2380
-23,692.2380
-24,497.9810
-12,033.2490
-15,091.3040
Net Income from Continuing Operation Net Minority Interest
-15,691.9930
-23,736.9930
-24,525.9230
-12,090.3390
-15,487.4720
Normalized EBITDA
-15,643.2380
-23,692.2380
-24,497.9810
-12,033.2490
-15,091.3040
12/31/2020 - 3/9/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

65G.F NextCell Pharma AB
0.2140
+15.36%
 
DIABIO.ST Diagonal Bio AB (publ)
0.0239
-7.36%
 
ACTI.ST Active Biotech AB (publ)
0.1080
-3.40%
 
NXTCL.ST NextCell Pharma AB
2.8400
+6.77%
 
SANION.ST Saniona AB (publ)
8.16
+0.49%
 
ENTO Entero Therapeutics, Inc.
0.6300
+1.88%
 
GRI GRI Bio, Inc.
0.7400
-3.90%
 
TARA Protara Therapeutics, Inc.
5.39
+4.05%
 
BCAB BioAtla, Inc.
0.6923
-41.82%
 
PRTG Portage Biotech Inc.
5.96
+1.88%